- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04214275
Pulmonary Rehabilitation and Quality of Life
December 30, 2019 updated by: Yeliz Ciğerci, Afyonkarahisar Health Sciences University
The Effect of Pulmonary Rehabilitation on Respiratory Functions and Quality of Life Following Coronial Artery Bypass Grafting: a Randomized Controlled Trial
In this study, the effect of a pulmonary rehabilitation (PR) program on the respiratory function and quality of life of patients undergoing CABG surgery with an open-heart technique is examined.
A randomized controlled experimental design was used.
The study was conducted with two groups: the intervention group (n=25) and control group (n=25).
The control group received standard care after CABG.
In contrast, the experimental group, in addition to standard care, participated in a PR program created by the researchers.
After CABG, the respiratory functions of both groups (clinical care day 4) and quality of life (6th week) evaluated
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Centre
-
Afyonkarahisar, Centre, Turkey, 03200
- Afyonkarahisar Health Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who were extubated in twenty-four hours,
- aged 18 or above,
- had undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
- who were conscious,
- without visual and hearing problems,
- who spoke Turkish,
- had not orthopedic, psychiatric and neurological problems,
- no co-morbid lung disease,
- who had not been re-operated on,
- had not postoperative cardiac dysfunction,
- had not developed postoperative atrial fibrillation,
- who were willing to participate in the study.
Exclusion Criteria:
- Patients who were not extubated in twenty-four hours,
- who were under 18 years of age,
- had not undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
- who were not conscious,
- were visual and hearing problems,
- who don't spoke Turkish,
- had orthopedic, psychiatric and neurological problems,
- co-morbid lung disease,
- who had been re-operated on,
- had postoperative cardiac dysfunction,
- had developed postoperative atrial fibrillation,
- who were not willing to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention group
standard care and participated in a pulmonary rehabilitation program
|
Simple breathing techniques, secretion-removal techniques, airway-cleaning techniques, mobilization techniques and use of an incentive spirometer
|
No Intervention: control group
received standard care after coronary artery bypass graft
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Pulmonary Function Test (PFT)
Time Frame: Preoperative day
|
A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction.
The PFT assessment was performed using the NDD Easy on-PC spirometer.
During this test, challenging expiratory volume (FEV1 % (>80)), challenging vital capacity (FVC % (>80)), FEV1/FVC ( %, >80) ratio, and Peak Expiratory air pressure (PEF % (>100)) were measured in the first second.
The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively.
|
Preoperative day
|
The Pulmonary Function Test (PFT) Change
Time Frame: 4th day of clinical care
|
A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction.
The PFT assessment was performed using the NDD Easy on-PC spirometer.
During this test, challenging expiratory volume (FEV1 % (>80)), challenging vital capacity (FVC % (>80)), FEV1/FVC ( %, >80) ratio, and Peak Expiratory air pressure (PEF % (>100)) were measured in the first second.
The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively.
The PFT was performed in the Chest Diseases Outpatient Clinic of the 4th day of clinical care.
|
4th day of clinical care
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Short-Form Health Survey (SF-36)
Time Frame: preoperative day
|
The points given vary between 0-100; 0 points indicate bad health and 100 points indicate that health is progressing in a good direction.
|
preoperative day
|
The Short-Form Health Survey (SF-36) Change
Time Frame: postoperative sixth week
|
The points given vary between 0-100; 0 points indicate bad health and 100 points indicate that health is progressing in a good direction.
|
postoperative sixth week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yeliz Ciğerci, PhD, +90 272 444 0304
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
December 29, 2017
Study Completion (Actual)
December 29, 2017
Study Registration Dates
First Submitted
December 26, 2019
First Submitted That Met QC Criteria
December 27, 2019
First Posted (Actual)
January 2, 2020
Study Record Updates
Last Update Posted (Actual)
January 2, 2020
Last Update Submitted That Met QC Criteria
December 30, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2016/806
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Bypass Graft
-
Riphah International UniversityCompleted
-
Loma Linda UniversityEdwards LifesciencesCompletedCoronary Artery Bypass GraftUnited States
-
Montreal Heart InstituteCompletedCoronary Artery Bypass GraftCanada
-
University of Sao PauloFundação ZerbiniCompletedCoronary Artery Bypass Graft SurgeryBrazil
-
South Valley UniversityActive, not recruitingCoronary Artery Bypass Graft SurgeryEgypt
-
North Texas Veterans Healthcare SystemUnknownCoronary Artery Bypass Graft SurgeryUnited States
-
Liang ZhangUnknownCoronary Artery Bypass Graft Triple VesselChina
-
Hadassah Medical OrganizationUnknownComplication of Coronary Artery Bypass Graft
-
Centre hospitalier de l'Université de Montréal...Centre de Recherche du Centre Hospitalier de l'Université de MontréalUnknownGraft Failure | Complications Due to Coronary Artery Bypass GraftCanada
-
Seoul National University HospitalCompletedCoronary Artery Bypass Graft Triple VesselKorea, Republic of
Clinical Trials on pulmonary rehabilitation
-
Faculty of Medicine, SousseCompletedChronic Obstructive Pulmonary DiseaseTunisia
-
Universidade Federal de Santa MariaCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Istanbul Medipol University HospitalRecruitingLung Diseases | Bronchiectasis | Lung Diseases, Interstitial | Pulmonary RehabilitationTurkey
-
Aveiro UniversityCentro Hospitalar do Baixo VougaRecruitingChronic Obstructive Pulmonary Disease | Interstitial Lung DiseasePortugal
-
National Cheng-Kung University HospitalCompletedTelerehabilitation | Pulmonary Rehabilitation | Compliance, Patient | COPD | Cardiopulmonary Exercise TestTaiwan
-
Istanbul Medipol University HospitalCompletedEmphysema | Bronchoscopic Lung Volume Reduction | Hospital-based Pulmonary Rehabilitation | Home-based Pulmonary RehabilitationTurkey
-
La Trobe UniversityMonash University; The Alfred; Austin HealthCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
Hospital Clinic of BarcelonaSociedad Española de Neumología y Cirugía TorácicaUnknownNon-cystic Fibrosis Bronchiectasis
-
University of MaltaCompletedInterstitial Lung DiseaseMalta
-
University of MaltaNot yet recruitingChronic Obstructive Pulmonary Disease